News

AddToAny

Google+ Facebook Twitter Twitter

Patient zero discovered?

A person on a poorly ventilated Chinese bus infected nearly two dozen other passengers with coronavirus and may be patient zero, it is claimed.

The new research probes the threat of airborne infection by taking a close look at passengers who made a 50-minute trip to a Buddhist event in the eastern Chinese city of Ningbo aboard two buses in January.

The scientists believe a passenger on the bus was likely patient zero because the person had been in contact with people from Wuhan.

The scientists managed to map out where the other passengers sat, and test them for the virus, with 23 of 68 passengers subsequently confirmed as infected.

What is notable is that the sickness infected people in the front and back of the bus, outside the perimeter of 1–2 metres that authorities and experts say infectious droplets can travel.

On top of that, the sick passenger was not yet showing symptoms of the disease, such as a cough, when the group made their trip.

The paper states: “The investigations suggest that, in closed environments with air recirculation, SARS-CoV-2 is a highly transmissible pathogen.”  

bit.ly/2GH6gvG

 

Picture Credit | Getty Images

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top